ABX
Abacus Global Management, Inc.
ABX has a slight edge over MS overall, supported by stronger fundamentals and stronger valuation.
MS
Morgan Stanley
MS has lower modeled downside risk, despite its lower overall score.
ABX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
ABX's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like ABX.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
ABX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 7.5x | $8.78 | — |
| Cheap | 25x | $6.77 | -23% |
| Fair | 32x | $8.54 | -2.7% |
| Current | 33x | $8.78 | — |
| Expensive | 209x | $56.46 | +543% |
Historical ranges are pointers, not guarantees.
ABX has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
ABX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for ABX, with profitability improving.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
ABX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.17 | +333% |
| Q2 2026 | $0.27 | +$0.37 |
| Q1 2026 | $0.38 | +$0.65 |
| Q4 2025 | $0.36 | +$0.70 |
| Q3 2025 | $0.04 | +$0.26 |
| Q2 2025 | -$0.10 | +$0.04 |
| Q1 2025 | -$0.27 | -$0.25 |
ABX has returned to profit: it earned $0.27 per share over the past year, after losing money the year before.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over ABX on earnings, with more consistent year-over-year improvement.
ABX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $73M | +30% |
| Q1 2026 | $59.4M | +35% |
| Q4 2025 | $71.9M | +116% |
| Q3 2025 | $63M | +124% |
| Q2 2025 | $56.2M | +93% |
| Q1 2025 | $44.1M | +105% |
| Q4 2024 | $33.2M | +40% |
| Q3 2024 | $28.1M | +33% |
ABX has the edge over MS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 29% | -11 points |
| Q1 2026 | 31% | -17 points |
| Q4 2025 | 32% | +82 points |
| Q3 2025 | 36% | +11 points |
| Q2 2025 | 40% | +17 points |
| Q1 2025 | 48% | +37 points |
| Q4 2024 | -50% | -59 points |
| Q3 2024 | 24% | -5.5 points |
ABX's operating margin was 29% last quarter, down 11 points from the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over ABX on profitability, with a higher operating margin.
ABX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $38.4M | -49% |
| Q1 2026 | $91.6M | +$153.4M |
| Q4 2025 | -$7.6M | +$84.6M |
| Q3 2025 | -$32.9M | +$19.6M |
| Q2 2025 | $75.7M | +$142.7M |
| Q1 2025 | -$61.8M | -3036% |
| Q4 2024 | -$92.2M | -$78.7M |
| Q2 2024 | -$67M | -$29.1M |
ABX has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
ABX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.1% | -1.1M shares |
| 1 year | +1.1% | +1.1M shares |
| 3 years | +128% | +55.3M shares |
ABX has 98M diluted shares, up 1.1% from a year ago, despite $33M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $9.9M |
| Q1 2026 | $14.5M |
| Q4 2025 | $5.5M |
| Q3 2025 | $3.2M |
| Q2 2025 | $35.1M |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
ABX spent $33M buying back its own shares over the past year, down 5.6% from the year before.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over ABX on shareholder dilution, with a more favorable share count trend.
ABX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 3.0x | Elevated |
| Q1 2026 | 2.8x | Moderate |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.9x | High |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -1.5x | Net Cash |
| Q4 2024 | -18.7x | Net Cash |
| Q3 2024 | -0.2x | Net Cash |
ABX has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
ABX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.3 | Neutral |
| Stochastic | 35.8 | Neutral |
ABX's weekly RSI is 48 (neutral) and its Stochastic is 36 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
ABX PE vs Financial Services Sector
| Metric | ABX | Sector median | Relative |
|---|---|---|---|
| PE | 33x | 13x | 150% above |
| PE % | 53 | 62 | 9 pts below |
ABX is trading at 33x earnings, a 150% premium to the Financial Services sector's median of 13x.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over ABX on valuation relative to its sector.
ABX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.36 | 5% above |
| 20 week MA | $9.35 | 6.1% below |
| 50 week MA | $8.97 | 2.1% below |
| 100 week MA | $7.90 | 11% above |
| 200 week MA | $8.72 | 0.7% above |
ABX's trend is mixed: it's above three of its five weekly moving averages, and 0.7% above its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
ABX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.76 | $9.98 | +2.3% |
| 2021 | $9.98 | $9.86 | -1.2% |
| 2022 | $9.86 | $10.1 | +2.5% |
| 2023 | $10.1 | $9.66 | -4.5% |
| 2024 | $9.66 | $7.75 | -20% |
| 2025 | $7.75 | $8.50 | +9.7% |
| 2026 YTD | $8.50 | $8.78 | +3.3% |
ABX has finished lower in three of the last six years. It's up 3.3% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over ABX on returns for 2026, with the stronger performance.